AUSTIN, May 2024: Ernst & Young LLP (EY US) announced that Beth San Segundo, President & CEO of OriGen Biomedical, was named an Entrepreneur of the Year® 2024 Gulf South Award finalist. The Gulf South program celebrates entrepreneurs from Central and South Texas, Louisiana, and Mississippi. Now in its 38th year, Entrepreneur of the Year is the preeminent competitive business award for audacious leaders who disrupt markets, revolutionize sectors, and have a transformational impact on lives. Over the past four decades, the program has recognized the daring entrepreneurs with big ideas and bold actions that reshape our world.
Beth San Segundo was one of the regional entrepreneurs selected as finalists by an independent panel of judges. The candidates were evaluated based on their demonstration of building long-term value through entrepreneurial spirit, purpose, growth, and impact, among other core contributions and attributes.
“Being named a finalist for the Entrepreneur of the Year® 2024 Gulf South Award is a tremendous honor,” said San Segundo. “Our team is dedicated to producing quality medical devices and improving patient outcomes, and this recognition validates our commitment to making a positive impact in healthcare. The deep-seated entrepreneurial spirit at OriGen traces back to my father, Richard Martin. Over 25 years ago, he founded OriGen and embarked on a journey to create innovative solutions to improve patient care. I am honored to lead the company with the same passion and commitment to innovation and proud of what we’ve achieved thus far. We are excited about the opportunities ahead as we continue to support the cell & gene therapy industry.”
Entrepreneur of the Year honors many different types of business leaders for their ingenuity, courage, and entrepreneurial spirit. The program celebrates founders who bootstrapped their business from inception or who raised outside capital to grow their company; transformational CEOs who infused innovation into an existing organization to catapult its trajectory; and multigenerational family business leaders who reimagined a legacy business model to fortify it for the future.
Regional award winners will be announced on June 13, 2024, during a special celebration and will become lifetime members of an esteemed community of Entrepreneur of the Year alumni from around the world. The winners will then be considered by the National judges for the Entrepreneur of the Year National Awards, which will be presented in November at the annual Strategic Growth Forum®, one of the nation’s most prestigious gatherings of high-growth, market-leading companies.
In addition to Entrepreneur of the Year, EY US supports other entrepreneurs through the EY Entrepreneurial Winning Women™ program and the EY Entrepreneurs Access Network to help connect women founders and Black and Hispanic/Latino entrepreneurs, respectively, with the resources, network, and access needed to unlock their full potential.
Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur of the Year Awards include presenting sponsors PNC Bank, Cresa, Marsh USA, SAP, and the Ewing Marion Kauffman Foundation. In the Gulf South, sponsors also include ADP, DLA Piper, Marsh McLennan Agency, vcfo, Big Picture Inc., and Pierpont Communications.
ABOUT ENTREPRENEUR OF THE YEAR®
Founded in 1986, Entrepreneur of the Year® has celebrated more than 11,000 ambitious visionaries who are leading successful, dynamic businesses in the US, and it has since expanded to nearly 80 countries and territories globally. The US program consists of 17 regional programs whose panels of independent judges select the regional award winners every June. Those winners compete for national recognition at the Strategic Growth Forum® in November, where National finalists and award winners are announced. The overall National winner represents the US at the World Entrepreneur of the Year® competition. Visit ey.com/us/eoy.
ABOUT EY
EY exists to build a better working world, helping to create long-term value for clients, people and society and build trust in the capital markets. Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform, and operate. Working across assurance, consulting, law, strategy, tax, and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today. EY refers to the global organization and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ey.com.
ABOUT ORIGEN BIOMEDICAL
OriGen Biomedical, Inc. is a leading producer of cryopreservation and cell culture products. OriGen’s focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. Our products are designed with the patient and user in mind, and we strive to maintain excellent customer service to ensure that patient care is the priority. Quality is the foundation of all product designs at OriGen, and each product is produced with the intention that it will improve patient health. Founded in 1997 and headquartered in Austin, Texas, OriGen is certified annually to ISO 13485 standards and regularly inspected by the FDA, MDSAP, ISO certification organizations, and our customers. To learn more, visit origen.com and follow us on LinkedIn and Twitter.
Contact:
Paige Sohovich – Marketing Coordinator
OriGen Biomedical, Inc.
p.sohovich@origenbio.com
512-474-7278
